The Day My Cancer Finally Had a Name
The Day My Cancer Had a Name: Hearing “Uterine Leiomyosarcoma”
After the biopsy of the lump on my back, I still did not know exactly what the pathologist had found.
No one had explained the results to me yet.
But I knew they had found something.
I knew the lump was not just a sore spot from kayaking. I knew it was not an ordinary bump that could be forgotten. Deep inside, I believed that whatever was growing on my back was connected to the large masses inside my abdomen.
Once again, I was left waiting.
I wanted someone to tell me what it was.
More than anything, I wanted to know what we were going to do to get it out of my body.
The Pathology Department Told Me to Call the Doctor
After the biopsy, someone from pathology suggested that I schedule an appointment with my doctor.
That told me enough to know the result was important.
I called and made the appointment, but the doctor could not see me immediately. The appointment was still several days away.
Several days may not sound like a long time under ordinary circumstances.
When you believe someone has just found cancer in your body, several days can feel endless.
I did not want to wait for the scheduled appointment.
I wanted answers the moment the pathologist saw the sample.
I wanted someone to tell me whether the lump was related to the abdominal masses. I wanted to know whether it had spread. I wanted to know when surgery would happen and what treatment would follow.
Instead, I had to continue living with the knowledge that something was wrong while still not knowing its name.
Knowing Something Is Wrong Without Knowing What It Is
The mind does not handle that kind of uncertainty well.
You start trying to read meaning into every phone call.
You wonder why the appointment was scheduled.
You remember the expression on the person's face performing the biopsy.
You replay every word.
You search for clues that may not actually tell you anything.
At that point, I had three large abdominal masses and another mass on my back. I did not need anyone to tell me that the situation was serious.
I knew.
What I did not know was what type of cancer I had, how aggressive it was, how far it had spread, or whether the doctors could treat it.
Without a name, I could not begin to understand the enemy.
The Doctor Finally Said the Words
When I arrived at the doctor’s office, she finally told me what the pathology had found.
I had "uterine leiomyosarcoma".
What Is Uterine Leiomyosarcoma?
Uterine leiomyosarcoma is often shortened to uLMS. Uterine leiomyosarcoma is a rare type of cancer that begins in the smooth muscle of the uterus. It is a form of uterine sarcoma and is different from the more common cancers that begin in the lining of the uterus. Because uterine leiomyosarcoma is rare, diagnosis and treatment can be complex, and the outlook can vary from person to person depending on factors such as the stage of the cancer, whether it has spread, tumor characteristics, and how it responds to treatment.
It was a long medical name.
I had never heard it before.
I am not sure I could have repeated it correctly when I first left the office.
But after weeks of living with unnamed masses, my cancer finally had a name.
That name brought a strange combination of relief and terror.
I was relieved that someone finally knew what was wrong.
I was terrified by what she said next.
“This Is an Aggressive Cancer”
The doctor told me that uterine leiomyosarcoma was aggressive.
She made it clear that this was not a slow or simple cancer.
Uterine leiomyosarcoma is rare, and its behavior and outlook can vary depending on factors such as stage, tumor location, whether the cancer can be surgically removed, and how it responds to treatment. Surgery is a central treatment when it is possible, while chemotherapy, radiation, targeted therapy, hormone therapy, or clinical trials may be considered depending on the individual situation.
At that moment, however, I was not thinking through treatment categories.
I heard the word "aggressive".
My mind immediately translated that into another word:
"death."
The doctor talked about the seriousness of the cancer and its high death rate.
I needed to know the numbers.
I Asked for the Survival Statistics
I asked her directly about the statistics.
She refused to give me a number.
She told me she did not like giving people survival statistics because they often hear a number and immediately assume they will be on the worst side of it.
She told me that I could find the statistics myself.
Then she said something that stayed with me:
“You never know which side of the statistics you are going to be on.”
She wanted me to remember that a survival statistic describes a group of people.
It does not predict exactly what will happen to one individual.
The National Cancer Institute explains that prognosis statistics are based on groups of people who had the same or similar disease. They can help estimate what may happen, but they cannot tell an individual patient exactly what will happen.
That distinction mattered.
I was not a percentage.
I was one person with one body, one medical history, one cancer, and one treatment journey that had not happened yet.
The Numbers Were Frightening
Of course, I eventually searched for the statistics.
Many patients do.
The numbers associated with uterine leiomyosarcoma were frightening, especially when cancer had spread beyond the uterus.
Current American Cancer Society figures, based on women diagnosed from 2015 through 2021, list five-year relative survival rates for uterine leiomyosarcoma at approximately 61 percent for localized disease, 28 percent for regional disease, and 13 percent for distant disease. The combined rate across all stages is approximately 38 percent. These figures are estimates for large groups and may not reflect newer treatments or the circumstances of an individual patient.
Those statistics are also updated over time.
The numbers available when I was diagnosed were based on people treated in earlier years. New treatments, improved testing, targeted medications, clinical trials, and better understanding of tumor biology may not yet be fully represented in published survival data.
That does not mean the statistics should be ignored.
It means they should be understood for what they are.
They are information.
They are not a personal expiration date.
I Had Already Made My Decision to Fight
Before I ever knew the name uterine leiomyosarcoma, I had made a decision during the six-hour drive home from that Memorial Day camping trip.
I was going to fight.
That did not mean I believed I could control every result.
It did not mean I would never become scared.
It did not mean I would smile through every procedure or pretend treatment was easy.
It meant that I would show up.
I would ask questions.
I would accept treatment.
I would search for options.
I would keep moving forward as long as there was another step available.
The doctor talked about the importance of positive and how that has helps with coping.
Those words encouraged me.
However, I also want to be careful about what we tell patients about positivity.
A Positive Attitude Is Not a Cancer Treatment
Hope can help a person cope.
A determined attitude may help someone attend appointments, communicate with doctors, remain connected to others, participate in rehabilitation, and continue taking practical steps during treatment.
But a person does not cause a poor cancer outcome by feeling afraid, angry, sad, exhausted, or discouraged.
The National Cancer Institute states that there is no convincing scientific evidence showing that a person’s attitude determines whether they develop cancer or die from it. It is normal for people with cancer to feel hopeful on some days and frightened or discouraged on others.
That is important because “stay positive” can become a burden.
Patients may begin hiding their real emotions because they are afraid that crying, worrying, or admitting exhaustion will somehow make their cancer worse.
Cancer does not work that way.
You are allowed to have bad days.
You are allowed to be angry.
You are allowed to grieve.
You are allowed to admit that you are scared.
Hope does not require pretending.
What Fighting Cancer Really Meant to Me
Fighting cancer was not about smiling every day.
Sometimes fighting meant getting out of bed when I did not feel like moving.
Sometimes it meant allowing doctors to perform another procedure.
Sometimes it meant taking medication that caused difficult side effects.
Sometimes it meant asking for help.
Sometimes it meant resting.
Sometimes it meant crying and then deciding to face the next day anyway.
A fighting attitude is not a constant emotion.
It is a continuing decision.
You can feel emotionally broken and still decide to attend your appointment.
You can be terrified and still ask another question.
You can cry during treatment and still be fighting.
I Am Now on the Other Side of Five Years
The doctor’s words stayed with me throughout treatment:
“You do not know which side of the statistics you will be on.”
Years later, I reached my five-year mark.
I had outlived the outcome I feared when I first searched the survival numbers.
I had reached a milestone that once seemed almost impossible.
That does not mean the statistics were false.
It means statistics could not tell my entire story.
They could not account for every detail of my cancer, my treatment, my tumor markers, the medications that became available to me, the way my body responded, or the decisions my medical team would make.
They could not look forward in time and see me reaching five years.
I am deeply aware that not every patient receives that outcome. Reaching a milestone does not mean I fought harder, prayed better, or stayed more positive than someone who died.
Cancer outcomes are influenced by biology, stage, available treatments, response to therapy, access to care, other health conditions, and many factors patients cannot control.
I did not earn survival by having better thoughts.
I am grateful for it.
Survival Statistics Can Inform You Without Defining You
Some people want to know every statistic.
Other people do not want to hear the numbers at all.
Neither choice is automatically wrong.
You may find the numbers helpful because they allow you to understand the seriousness of your condition, prepare questions, organize your affairs, or evaluate treatment decisions.
You may find them emotionally overwhelming and prefer to receive only the information necessary to make the next decision.
The National Cancer Institute notes that some patients want detailed prognosis information while others prefer less. Patients can tell their doctors how much they wish to know and ask the doctor to explain what the numbers mean for their specific situation.
The most important thing is not simply finding a percentage online.
It is asking what the number does and does not mean.
Questions to Ask About Cancer Statistics
When a doctor discusses prognosis, consider asking:
Does this statistic apply to my exact type of cancer?
Does it apply to my stage?
How old is the data behind this number?
Were the patients in the study treated the same way I will be treated?
Does the statistic include newer medications or targeted therapies?
Are there features of my tumor that may affect my outlook?
What factors are favorable in my case?
What factors are concerning?
What is the goal of my treatment?
Is the goal cure, long-term control, symptom relief, or a combination?
Are there treatments or clinical trials not reflected in older survival data?
How will we know whether my treatment is working?
A percentage without context may create more fear than understanding.
What Does “Five-Year Survival” Mean?
Many people misunderstand the phrase “five-year survival rate.”
It does not mean that people who survive five years suddenly die at the five-year point.
A five-year relative survival rate compares people with a particular cancer to people in the general population who are similar in age and other broad characteristics. It estimates the percentage who are alive five years after diagnosis compared with those who do not have that cancer.
Some patients live much less than five years.
Others live five, ten, fifteen, or more years.
The statistic describes what happened across a group.
It does not place a timer inside an individual body.
Rare Cancer Statistics Have Limits
Uterine leiomyosarcoma is rare.
Uterine sarcomas represent only about 5 percent of uterine cancers, and leiomyosarcoma is one of the more common uterine sarcoma types. Because the disease is uncommon, it can be difficult to conduct large studies and compare treatments as easily as researchers can for more common cancers.
Rare cancer statistics may combine patients with different tumor stages, treatments, ages, health conditions, and disease characteristics.
They may also lag behind modern medicine.
For example, research continues to evaluate new drug combinations, targeted treatments, and hormone-based approaches for selected leiomyosarcomas. An NCI report in 2024 described improved survival in a clinical trial using a combination of doxorubicin and trabectedin for advanced leiomyosarcoma, showing how treatment knowledge continues to develop.
That does not mean every newer treatment is right for every patient.
It means the medical world does not stop changing when a survival table is published.
I Left the Office With a Name but Without a Complete Plan
The appointment gave me the name of my cancer.
It did not answer every question.
I still needed to understand the relationship between the back tumor and the abdominal masses.
I still needed surgery.
The doctors still needed more tissue and more information.
They needed to determine the extent of the disease and decide what treatment would follow.
Hearing the diagnosis did not instantly turn uncertainty into clarity.
It replaced one set of questions with another.
Before the appointment, I kept asking:
“What is it?”
After the appointment, the questions became:
“How far has it spread?”
“Can they remove it?”
“What treatment will I need?”
“Will I lose my hair?”
“Will I be able to work?”
“What will happen to my children if I die?”
“How do I tell my family?”
“What do I do now?”
The First Hours After a Cancer Diagnosis
People may imagine that once a diagnosis is given, the patient immediately begins making organized treatment decisions.
That was not how it felt.
My brain was trying to understand a word I had never heard before.
"Leiomyosarcoma."
I had to learn how to say it.
Then I had to learn what it meant.
I had to figure out how to explain it to my family when I barely understood it myself.
This is one reason a support person, notebook, medical guide, patient portal, or permitted recording can be so important during major appointments. Stress can make it difficult to absorb and remember unfamiliar information.
If you have just received a cancer diagnosis, you do not need to understand your entire future before leaving the office.
You need to understand the next step.
What to Do After Hearing a Rare Cancer Diagnosis
Ask the Doctor to Write Down the Exact Name
Cancer names can sound similar while referring to very different diseases.
Ask for:
The complete diagnosis
The pathology wording
The suspected site where the cancer began
The grade, if known
The stage, if known
Copies of the biopsy and imaging reports
Ask Whether the Pathology Needs Expert Review
Rare cancers can be difficult to classify.
Patients may ask whether the pathology should be reviewed by a pathologist who specializes in sarcoma or gynecologic cancers, particularly before major treatment decisions are finalized.
Ask What Is Known and What Is Still Unknown
A biopsy may identify the cancer type without answering every question about stage, spread, or treatment.
Ask the doctor to separate the information into three parts:
1. What we know now
2. What we suspect
3. What additional tests or surgery must determine
Write Down the Immediate Plan
Before leaving, know:
Which appointment comes next
Whether surgery is scheduled
Whether additional imaging is needed
Who is coordinating care
Who will call with results
What symptoms require urgent attention
Whether a second opinion is recommended
Whether you should see a sarcoma specialist
Be Careful With Internet Searches
Searching a rare cancer name can immediately bring up frightening numbers and stories.
Begin with trusted organizations such as:
National Cancer Institute
American Cancer Society
Foundation for Women’s Cancer
Society of Gynecologic Oncology
Major sarcoma centers
Peer-reviewed medical sources recommended by your care team
.gov sites
Online patient groups can provide valuable emotional support and lived experience, but another patient’s course does not predict your own.
What I Wish Someone Had Told Me
I wish someone had told me that receiving the diagnosis would not end the uncertainty.
It would simply give the uncertainty a name.
I wish someone had explained that survival statistics describe groups, not individuals.
I wish someone had told me that I could read the numbers without surrendering my future to them.
I wish someone had told me that being hopeful did not require me to hide my fear.
Most of all, I wish someone had told me that five years later I would still be here, repeating the doctor’s words to other people:
“You do not know which side of the statistics you will be on.”
Assume the Good Side of the Statistics
I understand why people assume the worst.
When a doctor calls a cancer aggressive, your mind naturally goes to the possibility of death.
When a website shows a low survival rate, it can feel as if your future has already been calculated.
It has not.
Take the illness seriously.
Learn what you need to learn.
Ask about treatment options.
Seek another opinion when appropriate.
Prepare for difficult days.
But leave room for the possibility that your story may not end where fear says it will.
Modern medicine continues to change.
New treatments continue to be studied.
Every person responds differently.
You may be the person on the better side of the number.
I was.
Hope for Today
The day I heard “uterine leiomyosarcoma,” I left the doctor’s office with a rare, aggressive cancer and no idea what the rest of my life would look like.
I did not know whether I would reach five years.
I only knew I had decided to fight for more time.
Today, I have passed that five-year milestone.
I cannot promise another patient the same outcome.
No honest person can.
But I can tell you that a frightening statistic is not the same thing as a final answer.
Listen to the medical facts.
Build the strongest care team available to you.
Allow yourself to feel every real emotion.
Then take the next step.
You may be standing at the beginning of a story that the statistics cannot yet see.
Frequently Asked Questions
What is uterine leiomyosarcoma?
Uterine leiomyosarcoma is a rare cancer that begins in the smooth muscle tissue of the uterus. It belongs to a group of cancers called uterine sarcomas and is different from the more common endometrial cancers that begin in the uterine lining.
Is uterine leiomyosarcoma aggressive?
It can be aggressive and may spread or return after treatment. The individual outlook depends on factors such as stage, tumor biology, whether the cancer can be removed, and response to treatment.
Can a doctor tell me exactly how long I will live?
No. Doctors can discuss prognosis using information from similar patients, but they cannot predict an exact outcome for one individual.
Does reaching five years mean the cancer can never return?
Not necessarily. The meaning of a five-year milestone varies by cancer type and individual situation. Patients should continue the follow-up schedule recommended by their oncology team.
Does a positive attitude improve cancer survival?
There is no convincing evidence that attitude alone determines whether someone dies from cancer. Hope, emotional support, and stress management may improve coping and help patients remain engaged in life and care, but negative emotions do not cause treatment failure.
Is it wrong to look up survival statistics?
No. Some people find statistics useful, while others find them overwhelming. Ask your doctor to explain how current statistics relate to your specific diagnosis, stage, tumor features, and treatment options.
Should a rare cancer diagnosis receive a second opinion?
A second opinion may be valuable, particularly when the diagnosis is rare, treatment is complex, or major surgery is planned. Patients can ask about review by a sarcoma or gynecologic oncology specialist.
Support on Your Journey
A rare cancer diagnosis can leave you surrounded by information while still feeling completely alone.
Surviving Life Lessons was created so people who have lived through difficult experiences can stand beside those who are just beginning them.
You may need medical expertise from your doctors.
You may also need someone who understands what it feels like to hear a frightening cancer name, search the statistics, wonder about your children, and still wake up the next morning determined to continue.
Both kinds of support matter.
Find Your Community
No one should have to face life's challenges alone. At Surviving Life Lessons, we believe in life survivors helping life strugglers. Explore our growing Community Groups to connect with others who understand your journey, share encouragement, and find hope through meaningful conversations. You'll also have the opportunity to introduce yourself and share your own story of overcoming. Your story matters. It may be the encouragement someone else needs to keep moving forward, reminding them that they are not alone and that hope is always possible.
Your Story Matters
We need your nice comments below! Your thoughts, experiences, and lessons learned might be exactly what someone else needs to hear today.
Drop a comment, Say Hello, and join the conversation.
Need More Personalized Support?
Everyone's journey is unique. If you're looking for personalized guidance, encouragement, or one-on-one support, explore our services to find the option that's right for you. We're here to help you take your next step with confidence and hope.
Helpful Resources for Your Journey
Explore our collection of books, journals, coloring books, and printable PDFs designed to encourage, inspire, and support you every step of the way.
References
National Leiomyosarcoma Foundation — New Diagnosis https://www.nlmsf.org/new-diagnosis National Cancer Institute. "Leiomyosarcoma." https://www.cancer.gov/types/soft-tissue-sarcoma/patient/leiomyosarcoma-treatment-pdq
National Cancer Institute. "Uterine Sarcoma Treatment." https://www.cancer.gov/types/uterine/patient/uterine-sarcoma-treatment-pdq
National Cancer Institute. "Understanding Cancer Prognosis." https://www.cancer.gov/about-cancer/diagnosis-staging/prognosis
National Cancer Institute. "Common Cancer Myths and Misconceptions." https://www.cancer.gov/about-cancer/causes-prevention/risk/myths
American Cancer Society. "Survival Rates for Uterine Sarcoma." https://www.cancer.org/cancer/uterine-sarcoma/detection-diagnosis-staging/survival-rates.html
American Cancer Society. "Key Statistics for Uterine Sarcoma." https://www.cancer.org/cancer/uterine-sarcoma/about/key-statistics.html
American Cancer Society. "Treating Uterine Sarcoma." https://www.cancer.org/cancer/uterine-sarcoma/treating.html
National Leiomyosarcoma Foundation. "What Is Leiomyosarcoma?" https://www.nlmsf.org/what-is-leiomyosarcoma
Cleveland Clinic. "Leiomyosarcoma." https://my.clevelandclinic.org/health/diseases/22477-leiomyosarcoma
About the Author:
Deborah Ann Martin is the founder of Surviving Life Lessons, a published author, poet, speaker, and trainer with over 20 years of management experience across multiple industries. An MBA graduate, U.S. veteran, single mother, and rare cancer survivor, Deborah brings both professional expertise and lived experience to her writing on resilience, leadership, personal growth, and overcoming adversity. Her mission is to empower others with practical wisdom and real-life insight to navigate life’s challenges with strength and purpose.
.png){kind=small}
Comments